CA
APGE icon

CoreCap Advisors’s Apogee Therapeutics APGE Stock Holding History

CoreCap Advisors’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$265 Buy
+2
New +$180 ﹤0.01% 2971

Other funds holding APGE

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM

CoreCap Advisors's APGE Position: Q2 2026 in Review

CoreCap Advisors opened a new position in Apogee Therapeutics (APGE) in Q2 2026: 2 shares worth $265. The stake represents ﹤0.01% of the portfolio and ranks #2971 among its holdings.

6 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • CoreCap Advisors held 2 shares of Apogee Therapeutics worth $265 as of Q2 2026.
  • Apogee Therapeutics was a new CoreCap Advisors position in Q2 2026.
  • Apogee Therapeutics made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2971 holding.
  • 6 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.